Reports for DARIFENACIN

Ingredient

DARIFENACIN

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DARIFENACIN 15MG TABLET (EXTENDED-RELEASE) Resolved 2022-01-14 2022-02-03 152758
APO-DARIFENACIN 15MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-01 2024-07-05 212368
APO-DARIFENACIN 7.5MG TABLET (EXTENDED-RELEASE) Resolved 2021-10-01 2022-01-24 146503
APO-DARIFENACIN 7.5MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-15 2024-10-11 213547
ENABLEX 7.5MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-20 2017-10-10 3487
ENABLEX 7.5MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-07 2019-01-03 68878
ENABLEX 7.5MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-09 2024-06-29 194461
ENABLEX 15MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-20 2017-10-10 3498
ENABLEX 15MG TABLET (EXTENDED-RELEASE) Resolved 2018-09-17 2023-08-16 61661
ENABLEX 15MG TABLET (EXTENDED-RELEASE) Resolved 2018-09-17 2018-12-15 61675

Showing 1 to 10 of 14

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports

Showing 1 to 0 of 0